FDA Investigator: Madushini N. Dharmasena

- Madushini N. Dharmasena first started conducting FDA inspections in 2019, with the last inspection in 2024. Over that time, Madushini N. Dharmasena has conducted 15 inspections at 15 companies across 15 sites.

Get Madushini Dharmasena's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 CSL Behring (Australia) Pty Ltd, Broadmeadows | 2024

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 Horizon Therapeutics Ireland DAC, Waterford | 2023

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 Dr. Reddy's Laboratories Ltd., Hyderabad | 2023

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 PharmaEssentia Corporation, Taichung Plant, Taichung | 2023

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 UCB Pharma S.A., Braine-L'Alleud | 2023

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 Bio-Technology General (Israel), Ltd., Kiryat Malchi | 2023

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 Byondis BV, Nijmegen | 2022

Out-of-stock
Madushini N. Dharmasena
Human Drugs Form 483

FDA 483 Samsung Biologics Co., Ltd., Incheon | 2022

Out-of-stock
Madushini N. Dharmasena
Human Drug Form 483

FDA 483 Hugel Inc. (Site 2), Chuncheon | 2021

Out-of-stock
Madushini N. Dharmasena
Human Drug Form 483

FDA 483 Regeneron Ireland Designated Activity Company, Limerick | 2021

Out-of-stock
Madushini N. Dharmasena
Human Drug Form 483

FDA 483 Janssen Sciences Ireland UC, Ringaskiddy | 2021

Out-of-stock
Madushini N. Dharmasena
Human Drug Form 483